Fundraising Fox

Noetik

South San Francisco, US · Founded 2022 · Delaware corporation · 53 employees on LinkedIn · 12 known investors

Find your way into Noetik

274 people in our graph share verified history with the Noetik team — schools, employers, funds. One of them is your warm intro.

Cameron Teitelmanunlockedknows Ron Alfa, MD, PhD · together at StartX (overlapped)
×8knows the team · via StartX
×3knows the team · via Stanford University School of Medicine

Noetik builds AI models to identify cancer patients most likely to respond to treatments and to discover new oncology drug targets. The platform aims to improve clinical trial patient selection and expand the set of viable cancer targets in drug development.

Founders & leadership

Noetik was founded in 2022 by Jacob Rinaldi, Ronald Alfa, and Ron Alfa, MD, PhD.

JRJacob Rinaldi
Jacob RinaldiinCo-Founder & CSO2022–2025
RA
Ronald AlfaCo-founder
RARon Alfa, MD, PhD
Ron Alfa, MD, PhDinCo-Founder & CEORon Alfa, MD, PhD, is a physician-scientist who has led therapeutics discovery and development teams across rare disease, oncology, immunology, and neuroscience. He is the founder of Noetik, which builds AI models to identify cancer patients likely to respond to treatments and to discover new oncology drug targets.

Board

JHJames Hardiman
James Hardimanin𝕏Investor and Board DirectorGeneral Partner at DCVC (Data Collective)
ASAmy Schulman
Amy SchulmaninBoard directorManaging Partner at Polaris Partners

Investors · 12

Also in the syndicate · 3

CJNV BioVenturesHummingbird Nomads FundIntermountain Ventures

Funding

SEC filings, press & company announcements

$62M disclosed across 3 rounds · 2022–2024

$40MraisedAug 2024 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James HardimanDirector
  • Jacob RinaldiExecutive Officer, Director, Promoter
  • Ronald AlfaExecutive Officer, Director, Promoter
  • Amy SchulmanDirector
Offering amount
$40M
Amount sold
$40M
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$8MraisedSep 2022 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ronald AlfaExecutive Officer, Director, Promoter
  • Jacob RinaldiExecutive Officer, Director, Promoter
  • James HardimanDirector
Offering amount
$8M
Amount sold
$8M
First sale
Aug 2022
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Noetik went on to found or lead other companies.

Competitors · 2

by search overlap

Companies competing with Noetik for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Noetik do?
Noetik builds AI models to identify cancer patients most likely to respond to treatments and to discover new oncology drug targets. The platform aims to improve clinical trial patient selection and expand the set of viable cancer targets in drug development.
Who founded Noetik?
Noetik was founded by Jacob Rinaldi, Ronald Alfa, Ron Alfa, MD, PhD in 2022.
Who are Noetik's investors?
Noetik's investors include 11.2 Capital, Breakout Ventures, Linearis Ventures, North South Ventures, Catalio Capital Management, DCVC (Data Collective), EPIC VENTURES, Polaris Partners and 1 more.
How much funding has Noetik raised?
Noetik has disclosed $62M raised across 3 rounds.
Where is Noetik headquartered?
Noetik is headquartered in South San Francisco, US.